This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (78)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

II. A Clinicopathological Study of 26 Patients With Carcinoma Metastatic to the Anterior Segment of the Eye

Andrew P. Ferry, MD; Ramon L. Font, MD

Arch Ophthalmol. 1975;93(7):472-482.

Abstract
In 26 of 227 patients with carcinoma metastatic to the eye or orbit, metastasis to the anterior uveal tract was the predominating feature. There was a definite propensity for the tumor to involve the horizontal meridian of the iris or ciliary body, rather than the upper or lower portions. The site of the primary tumor in the 26 patients was as follows: lung, 14; breast, 9; kidney, 2; and rectum, 1.

Ocular symptoms and signs produced by the metastatic tumors at onset or during the course of the disease included decreased vision (80%), a visible mass (72%), redness of the eye (56%), pain (56%), glaucoma (56%), iridocyclitis (44%), and hyphema (24%).

The median survival of the 26 patients with metastasis to the anterior segment of the eye was only 5.4 months from the time of ocular surgery. This is poorer than the median survival (7.2 months) of the patients with metastasis confined to the posterior segment, and much worse than the median survival (15.6 months) of the 28 patients with orbital involvement.

Author Affiliations
From the Registry of Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC, and the departments of ophthalmology and pathology, Mount Sinai School of Medicine, City University of New York.

Footnotes
Submitted for publication April 26, 1974.

This investigation is part of a thesis for membership in the American Ophthalmological Society.

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Reprint requests to Mount Sinai School of Medicine, Fifth Avenue and 100th Street, New York, NY 10029 (Dr. Ferry).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interferon alfa Therapy Against Metastatic Iris Tumor of Renal Cell Carcinoma
Ikeda et al.
Arch Ophthalmol 2000;118:846-847.
FULL TEXT  

Metastatic Bronchogenic Carcinoma of the Iris and Ciliary Body
de Rivas et al.
Arch Ophthalmol 1991;109:470-470.
ABSTRACT  

Metastatic Ciliary Body Carcinoid Tumor
Bardenstein et al.
Arch Ophthalmol 1990;108:1590-1594.
ABSTRACT  

Follicular Thyroid Cancer Metastatic to the Iris
Weisenthal et al.
Arch Ophthalmol 1989;107:494-495.
ABSTRACT  

Bilateral Retinal Metastases From Cutaneous Malignant Melanoma
Letson and Davidorf
Arch Ophthalmol 1982;100:605-607.
ABSTRACT  

B-K Mole Syndrome: Cutaneous and Ocular Malignant Melanoma
Abramson et al.
Arch Ophthalmol 1980;98:1397-1399.
ABSTRACT  

Iris Metastasis From a Bronchial Carcinoid Tumor
Rodrigues and Shields
Arch Ophthalmol 1978;96:77-83.
ABSTRACT